Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feedergsk.com
Press releases
Get the latest updates from Press releases directly as they happen.
Follow now 608 followers
Latest posts
Last updated 1 day ago
Jideytro (zidesamtinib) approved in the US for previously treated ROS1-positive non-small cell lung cancer
1 day ago
Next-generation design aims to address key efficacy and tolerability challenges of treating...
ViiV Healthcare to present phase IIIb data comparing Dovato with Biktarvy in treatment-naïve adults alongside INSTI-powered long-acting injectable innovation at AIDS 2026
3 days ago
VOGUE is the first head-to-head, randomised daily orals study comparing 2-drug regimen...
European Medicines Agency accepts submission to update Bexsero label for 1-dose Meningitis B booster in 10+ year olds
4 days ago
If approved, a single booster dose could help protect individuals who were...
GSK provides an update on CALM-1 and CALM-2 phase III trials for camlipixant in refractory chronic cough (RCC)
7 days ago
GSK plc (LSE/NYSE: GSK) today provides an update on the CALM-1 and...
GSK completes acquisition of Nuvalent, Inc.
9 days ago
GSK plc today announced completion of its acquisition of Nuvalent, Inc...
Jemperli (dostarlimab) achieves sustained clinical complete responses in dMMR/MSI-H locally advanced rectal cancer
11 days ago
Results support potential for dostarlimab to eliminate the need for chemotherapy, radiation...
GSK’s licensor Hansoh Pharma announces positive phase III results for Ris-Rez in China patient population
14 days ago
ARTEMIS-008 met its primary endpoint of overall survival in advanced or relapsed...
Roy Jakobs to join GSK Board as Non-Executive Director
15 days ago
Roy Jakobs will join the Board of the Company as a Non-Executive...
GSK announces commencement of tender offer to acquire Nuvalent, Inc.
30 days ago
GSK plc today announced that Harmony Row Acquisition Co. has commenced a...
Utebzi (tebipenem pivoxil) approved in the US for adults with complicated urinary tract infections (cUTIs)
about 1 month ago
More than 3 million cases of cUTIs are treated annually in the...
GSK’s momelotinib granted Orphan Drug Designations in the US and EU for VEXAS syndrome
about 1 month ago
ATLAS phase II/III trial in VEXAS underway, advancing momelotinib’s broader development programme.
GSK enters agreement to acquire Nuvalent, Inc.
about 1 month ago
Acquisition expected to be accretive to sales & core operating profit in...